These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of an aldose reductase inhibitor on type IV collagen production by human endothelial cells cultured in high glucose. Bakillah A, Grigorova-Borsos AM, Guillot R, Urios P, Sternberg M. Diabetologia; 1996 Jun; 39(6):641-8. PubMed ID: 8781759 [Abstract] [Full Text] [Related]
3. Stimulating effect of growth hormone on type IV collagen production by endothelial cells cultured in normal and high glucose. Bakillah A, Guillot R, Urios P, Grigorova-Borsos AM, Sternberg M. Amino Acids; 2012 Aug; 43(2):697-707. PubMed ID: 22002796 [Abstract] [Full Text] [Related]
5. Glycated albumin stimulation of PKC-beta activity is linked to increased collagen IV in mesangial cells. Cohen MP, Ziyadeh FN, Lautenslager GT, Cohen JA, Shearman CW. Am J Physiol; 1999 May; 276(5):F684-90. PubMed ID: 10330050 [Abstract] [Full Text] [Related]
6. Role of protein kinase C-angiotensin II pathway for extracellular matrix production in cultured human mesangial cells exposed to high glucose levels. Ikehara K, Tada H, Kuboki K, Inokuchi T. Diabetes Res Clin Pract; 2003 Jan; 59(1):25-30. PubMed ID: 12482638 [Abstract] [Full Text] [Related]
7. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F. J Biol Chem; 1991 Aug 25; 266(24):15771-81. PubMed ID: 1874734 [Abstract] [Full Text] [Related]
8. Differential modulation of human fibroblast and keratinocyte growth by the protein kinase C inhibitor GF 109203X. Le Panse R, Coulomb B, Mitev V, Bouchard B, Lebreton C, Dubertret L. Mol Pharmacol; 1994 Sep 25; 46(3):445-51. PubMed ID: 7935324 [Abstract] [Full Text] [Related]
9. Glucose-induced production of type IV collagen and laminin P1 from cultured human umbilical vein endothelial cells. Moritani S, Negishi K, Watanabe T, Shunto S, Serizawa N, Suzuki M, Takahashi M, Katayama S, Ishii J, Kawazu S. J Diabet Complications; 1991 Sep 25; 5(2-3):201-3. PubMed ID: 1770048 [Abstract] [Full Text] [Related]
10. Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance. Gekeler V, Boer R, Uberall F, Ise W, Schubert C, Utz I, Hofmann J, Sanders KH, Schächtele C, Klemm K, Grunicke H. Br J Cancer; 1996 Sep 25; 74(6):897-905. PubMed ID: 8826855 [Abstract] [Full Text] [Related]
11. [Protective effect of protein kinase C inhibitor Ro-31-8425 on hyperpermeability of human umbilical vein endothelial cells exposed to high glucose in vitro]. Zou M, Xue Y. Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec 25; 32(12):1787-91. PubMed ID: 23268411 [Abstract] [Full Text] [Related]
12. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. Koya D, Jirousek MR, Lin YW, Ishii H, Kuboki K, King GL. J Clin Invest; 1997 Jul 01; 100(1):115-26. PubMed ID: 9202063 [Abstract] [Full Text] [Related]
13. Increased expression of activated matrix metalloproteinase-2 by human endothelial cells after sublethal H2O2 exposure. Belkhiri A, Richards C, Whaley M, McQueen SA, Orr FW. Lab Invest; 1997 Nov 01; 77(5):533-9. PubMed ID: 9389796 [Abstract] [Full Text] [Related]
14. Exposure of human renal proximal tubular cells to glucose leads to accumulation of type IV collagen and fibronectin by decreased degradation. Phillips AO, Steadman R, Morrisey K, Martin J, Eynstone L, Williams JD. Kidney Int; 1997 Oct 01; 52(4):973-84. PubMed ID: 9328936 [Abstract] [Full Text] [Related]
15. The selective protein kinase C inhibitor GF 109203X inhibits phorbol ester-induced morphological and functional differentiation of SH-SY5Y human neuroblastoma cells. Heikkilä J, Jalava A, Eriksson K. Biochem Biophys Res Commun; 1993 Dec 30; 197(3):1185-93. PubMed ID: 8280132 [Abstract] [Full Text] [Related]
16. Plasma membrane-dependent activation of gelatinase A in human vascular endothelial cells. Lewalle JM, Munaut C, Pichot B, Cataldo D, Baramova E, Foidart JM. J Cell Physiol; 1995 Dec 30; 165(3):475-83. PubMed ID: 7593226 [Abstract] [Full Text] [Related]
17. Activation of a 66-kilodalton human endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine protease. Burns EH, Marciel AM, Musser JM. Infect Immun; 1996 Nov 30; 64(11):4744-50. PubMed ID: 8890235 [Abstract] [Full Text] [Related]
18. Soluble factor(s) released from neutrophils activates endothelial cell matrix metalloproteinase-2. Schwartz JD, Monea S, Marcus SG, Patel S, Eng K, Galloway AC, Mignatti P, Shamamian P. J Surg Res; 1998 Apr 30; 76(1):79-85. PubMed ID: 9695744 [Abstract] [Full Text] [Related]
19. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. Schnaper HW, Grant DS, Stetler-Stevenson WG, Fridman R, D'Orazi G, Murphy AN, Bird RE, Hoythya M, Fuerst TR, French DL. J Cell Physiol; 1993 Aug 30; 156(2):235-46. PubMed ID: 8344982 [Abstract] [Full Text] [Related]
20. Activation of gelatinase A (72-kDa type IV collagenase) induced by monensin in normal human fibroblasts. Li L, Akers K, Eisen AZ, Seltzer JL. Exp Cell Res; 1997 May 01; 232(2):322-30. PubMed ID: 9168808 [Abstract] [Full Text] [Related] Page: [Next] [New Search]